Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) came to market through a de-SPAC merger between Mountain Crest Acquisition Corp. II and Better Therapeutics, a prescription digital therapeutics company developing software-based treatments for cardiometabolic diseases. Mountain Crest Acquisition Corp. II, sponsored by Mountain Crest Capital LLC, completed its blank-check IPO in January 2021 — the date of the 424B4 prospectus on record — placing it among the wave of healthcare-focused SPACs that went public during that period. The business combination closed later in 2021, with the combined entity listing on Nasdaq under the BTTX ticker in the digital health sector. The company subsequently faced commercial and financial challenges and was delisted from Nasdaq. Sign up on SpacDesk for full filing histories, sponsor profiles, and post-merger performance data across the entire SPAC universe.